N‐Acetylprocainamide kinetics and clinical response during repeated dosing

[1]  J. L. Powers,et al.  Measurement of procainamide and N-acetylprocainamide in serum by high-performance liquid chromatography. , 1997, Clinical chemistry.

[2]  D. Drayer,et al.  Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome. , 1981, Annals of internal medicine.

[3]  H. Kraemer,et al.  A New Method for Evaluating Antiarrhythmic Drug Efficacy , 1980, Circulation.

[4]  D. Roden,et al.  Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. , 1980, The American journal of cardiology.

[5]  D. Drayer,et al.  The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias. , 1980, The American journal of cardiology.

[6]  L B Sheiner,et al.  Forecasting individual pharmacokinetics , 1979, Clinical pharmacology and therapeutics.

[7]  R. Sung,et al.  Antiarrhythmic Drug Therapy in Survivors of Prehospital Cardiac Arrest: Comparison of Effects on Chronic Ventricular Arrhythmias Recurrent Cardiac Arrest , 1979, Circulation.

[8]  A Schumitzky,et al.  A program package for simulation and parameter estimation in pharmacokinetic systems. , 1979, Computer programs in biomedicine.

[9]  A. Atkinson,et al.  Long‐term antiarrhythmic therapy with N‐acetylprocainamide , 1979, Clinical pharmacology and therapeutics.

[10]  L. Horowitz,et al.  Electrocardiographic Findings in Patients with Obstructive and Nonobstructive Hypertrophic Cardiomyopathy , 1978, Circulation.

[11]  A. Atkinson,et al.  Dose‐ranging trial of N‐acetylprocainamide in patients with premature ventricular contractions , 1977, Clinical pharmacology and therapeutics.

[12]  A. Atkinson,et al.  Absolute bioavailability in man of N‐acetylprocainamide determined by a novel stable isotope method , 1975, Clinical pharmacology and therapeutics.

[13]  A. Atkinson,et al.  Antiarrhythmic potency of N‐acetylprocainamide , 1975, Clinical pharmacology and therapeutics.

[14]  R. Winkle,et al.  Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide. , 1981, The American journal of cardiology.

[15]  J. Strong,et al.  Pharmacokinetics in man of the N-acetylated metabolite of procainamide. , 1975, Journal of pharmacokinetics and biopharmaceutics.

[16]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..